Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy

D Tewari, P Patni, A Bishayee, AN Sah… - Seminars in cancer …, 2022 - Elsevier
Abstract The phosphatidylinositol 3-kinase (PI3K)-Akt and the mammalian target of
rapamycin (mTOR) represent two vital intracellular signaling pathways, which are …

The PI3K-Akt-mTOR signaling pathway in human acute myeloid leukemia (AML) cells

I Nepstad, KJ Hatfield, IS Grønningsæter… - International journal of …, 2020 - mdpi.com
Acute myeloid leukemia (AML) is a heterogeneous group of diseases characterized by
uncontrolled proliferation of hematopoietic stem cells in the bone marrow. Malignant cell …

Drug repurposing from the perspective of pharmaceutical companies

Y Cha, T Erez, IJ Reynolds, D Kumar… - British journal of …, 2018 - Wiley Online Library
Drug repurposing holds the potential to bring medications with known safety profiles to new
patient populations. Numerous examples exist for the identification of new indications for …

miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells

ER Lechman, B Gentner, SWK Ng, EM Schoof… - Cancer cell, 2016 - cell.com
To investigate miRNA function in human acute myeloid leukemia (AML) stem cells (LSC), we
generated a prognostic LSC-associated miRNA signature derived from functionally …

Targeting PI3K/Akt/mTOR in AML: rationale and clinical evidence

S Darici, H Alkhaldi, G Horne, HG Jørgensen… - Journal of Clinical …, 2020 - mdpi.com
Acute myeloid leukemia (AML) is a highly heterogeneous hematopoietic malignancy
characterized by excessive proliferation and accumulation of immature myeloid blasts in the …

The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer

A Arif, AA Alameri, UB Tariq, SA Ansari, HI Sakr… - International …, 2023 - Elsevier
Currently, cancer ranks as the second leading cause of death worldwide, and at the same
time, the burden of cancer continues to increase. The underlying molecular pathways …

Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia

SK Tasian, DT Teachey, Y Li, F Shen… - Blood, The Journal …, 2017 - ashpublications.org
Philadelphia chromosome (Ph)–like B-cell acute lymphoblastic leukemia (Ph-like ALL) is
associated with activated JAK/STAT, Abelson kinase (ABL), and/or phosphatidylinositol 3 …

Epigallocatechin gallate and mitochondria—a story of life and death

MR de Oliveira, SF Nabavi, M Daglia, L Rastrelli… - Pharmacological …, 2016 - Elsevier
Epigallocatechin gallate (EGCG) is a flavonoid belonging to the chemical class of falvan-3-
ols (catechins) esterified with gallic acid. It is the main catechin found in green tea (Camellia …

Molecular processes involved in B cell acute lymphoblastic leukaemia

C Malouf, K Ottersbach - Cellular and molecular life sciences, 2018 - Springer
B cell leukaemia is one of the most frequent malignancies in the paediatric population, but
also affects a significant proportion of adults in developed countries. The majority of infant …

Aberrant signaling pathways in T-cell acute lymphoblastic leukemia

D Bongiovanni, V Saccomani, E Piovan - International journal of …, 2017 - mdpi.com
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the
malignant transformation of immature progenitors primed towards T-cell development …